When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Strongyloides infection

Last reviewed: 17 Oct 2025
Last updated: 02 Aug 2023

Summary

Definition

病史和体格检查

关键诊断因素

  • history of soil exposure in an endemic area
  • infection with other parasites
完整详情

其他诊断因素

  • abdominal pain
  • altered bowel habit
  • weight loss
  • fever (hyperinfection)
  • signs of sepsis (hyperinfection)
  • chronic cough
  • wheezing
  • pruritus or dermatitis
  • larva currens
  • urticaria
  • cutaneous larva migrans
  • apparent drug reaction rash (hyperinfection)
  • other skin complaints
  • symptoms and signs of inflammatory bowel disease
完整详情

危险因素

  • soil exposure in or migrants from an endemic area of the world
  • international travelers
  • corticosteroids (risk of hyperinfection)
  • human T-cell lymphotropic virus type-1 (HTLV-1) infection (risk of hyperinfection)
  • impaired immunity
  • solid-organ transplant recipient
完整详情

诊断性检查

首要检查

  • stool ova and parasites (O&P) exam
  • CBC with differential
  • therapeutic trial with ivermectin (in specific situations)
完整详情

需考虑的检查

  • sputum O&P exam
  • clinical sample (nonstool or sputum) O&P exam
  • strongyloides IgG serology
  • tissue biopsy
完整详情

新兴检查

  • polymerase chain reaction (PCR)

治疗流程

初步治疗

immigrant from endemic area

急症处理

able to tolerate oral therapy: not critically ill (nonpregnant)

unable to tolerate oral therapy or critically ill (nonpregnant)

pregnant

持续性治疗

poor clinical response or initial treatment not completed

撰稿人

作者

David R. Boulware, MD, MPH, CTropMed
David R. Boulware

Professor of Medicine

Department of Medicine

University of Minnesota

Minneapolis

MN

利益声明

DRB is an author of a number of references cited in this topic.

同行评议者

Elizabeth Barnett, MD

Professor

Department of Pediatrics

Boston Medical Center

Boston University

Boston

MA

利益声明

EB declares that she is on a speaker's bureau for Merck. She is an author of a reference cited in this topic.

Linda Nield, MD, FAAP

Professor of Pediatrics

West Virginia University School of Medicine

Morgantown

WV

利益声明

LN is an author of a reference cited in this topic.

Geoff Gill, MA, MSc, MD, FRCP, DTMH

Professor of International Medicine and Honorary Consultant Physician

Liverpool School of Tropical Medicine

Liverpool

UK

利益声明

GG declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

参考文献

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

关键文献

World Gastroenterology Organisation. WGO practice guideline: management of strongyloidiasis. February 2018 [internet publication].全文

Loutfy MR, Wilson M, Keystone JS, et al. Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. Am J Trop Med Hyg. 2002 Jun;66(6):749-52. 摘要

Henriquez-Camacho C, Gotuzzo E, Echevarria J, et al. Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection. Cochrane Database Syst Rev. 2016 Jan 18;(1):CD007745.全文  摘要

参考文献

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

内容使用需遵循免责声明